Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alessandro Lentini
Sugar-Induced Modification of Fibroblast Growth Factor 2 Reduces Its Angiogenic Activity in Vivo
American Journal of Pathology
Forensic Medicine
Pathology
Related publications
Oligomerization Reduces Heparin Affinity but Enhances Receptor Binding of Fibroblast Growth Factor 2
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Elevated Levels of the Angiogenic Cytokines Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Sera of Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Diacetyloxyl Derivatization of the Fibroblast Growth Factor Inhibitor Dobesilate Enhances Its Anti-Inflammatory, Anti-Angiogenic and Anti-Tumoral Activities
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Fibroblast Growth Factor 2 Modulates Hippocampal Microglia Activation in a Neuroinflammation Induced Model of Depression
Frontiers in Cellular Neuroscience
Molecular Neuroscience
Cellular
Positive Correlation Between Estradiol and Vascular Endothelial Growth Factor but Not Fibroblast Growth Factor-2 in Normal Human Breast Tissue in Vivo
Clinical Cancer Research
Cancer Research
Oncology
AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor
Clinical Cancer Research
Cancer Research
Oncology
Heparan Sulphate Glycosaminoglycans Derived From Endothelial Cells and Smooth Muscle Cells Differentially Modulate Fibroblast Growth Factor-2 Biological Activity Through Fibroblast Growth Factor Receptor-1
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Injectable Fibroblast Growth Factor-2 Coacervate for Persistent Angiogenesis
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Oncometabolite D‑2‑hydroxyglutarate Induces Angiogenic Activity Through the Vascular Endothelial Growth Factor Receptor 2 Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology